Skip to main content
Log in

The long-term outcome of hepatitis B

Langfristige Folge der Hepatitis B

  • Originalia
  • Published:
Infection Aims and scope Submit manuscript

Summary

Among 466 hospitalized patients with serologically verified acute hepatitis B, 440 individuals (94.4%) could be followed up until normalization of liver function had occured, or for at least one year. In 90.2% of the patients followed-up liver function (including galactose tolerance) returned to normal within four months after onset of illness. Chronic persistent hepatitis (CPH) developed in 28 patients (6.4%) with persistence of hepatitis B surface antigen (HBs Ag) for at least one year in 14 patients (50%). Liver biopsy was performed in 20 of these 28 cases about a year after onset of illness and was consistent with CPH in all cases. Histological signs of chronic aggressive hepatitis developed in 15 patients (3.4%) and persistence of HBs Ag was observed in 11 of these patients (73%). No histological follow-up was performed in patients with normal liver function within four onths after onset of illness. Corticosteroid treatment in 56 patients with prolonged symptoms did not seem to predispose to persistence of HBs AG in the serum.

Zusammenfassung

Von insgesamt 466 stationären Patienten mit serologisch verifizierter akuter Hepatitis B konnten 440 (94,4%) bis zur Normalisierung der Leberfunktion oder mindestens ein Jahr nachbeobachtet werden. Bei 90,2% der nachbeobachteten Patienten normalisierte sich die Leberfunktion (einschließlich Galaktosetoleranz) binnen 4 Monaten nach Ausbruch der Krankheit. Chronisch persistierende Hepatitis entwickelte sich bei 28 Patienten (6,4%) mit Persistenz des Hepatitis-B-Oberflächenantigens (HBS AG) für die Dauer von mindestens einem Jahr bei 14 Patienten (50%). Bei 20 dieser 28 Fälle wurde ungefähr ein Jahr nach Ausbruch der Krankheit eine Leberbiopsie durchgeführt, die in allen Fällen dem Bild der chronisch persistierenden Hepatitis entsprach. Histologische Zeichen der chronisch aggressiven Hepatitis entwickelten sich bei 15 Patienten (3,4%) und bei 11 von ihnen (73%) wurde Persistenz des HBsAg festgestellt. Bei Patienten mit normaler Leberfunktion binnen 4 Monaten nach Ausbruch der Krankheit wurde keine histologische Kontrolluntersuchung vorgenommen. Die Kortikosteroidbehandlung von 56 Patienten mit langfristigen Symptomen schien nicht für die Persistenz von HBs AG im Serum zu prädisponieren.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature

  1. Iwarson, S., Hermodsson, S. Hepatitis-associated antigen in acute viral hepatitis. Scand. J. Infect. Dis. 3 (1971) 93–101.

    Google Scholar 

  2. Hansson, B. G., Kindmark, C.-O., Johnsson, T. Comparison between the immunoelectro-osmophoresis and the Ouchterlony precipitation technique in detecting Australia antigen in cases of hepatitis. Vox Sang. 19 (1970) 225–227.

    Google Scholar 

  3. Bianchi, L., de Groote, J., Desmet, V. J., Gedigk, P., Korb, G., Popper, H., Poulsen, H., Scheuer, P. J., Schmid, M., Thaler, H., Wepler, W. Morphological criteria in viral hepatitis: Review by an international group. Lancet I (1971) 333–337.

    Google Scholar 

  4. de Groote, J., Gedigk, P., Popper, H., Scheuer, P. J., Thaler, H., Desmet, V. J., Korb, G., Poulsen, H., Schmid, M., Thaler, H., Wepler, W. A classification of chronic hepatitis. Lancet II (1968) 626–628.

    Google Scholar 

  5. Iwarson, S., Lundin, P., Hermodsson, S. Liver morphology in acute viral hepatitis related to the hepatitis B antigen. J. clin. Pathol. 25 (1972) 850–855.

    Google Scholar 

  6. Nielsen, J. O., Dietrichson, O., Elling, P., Christoffersen, P. Incidence and meaning of persitence of Australia antigen in patients with acute viral hepatitis: Development of chronic hepatitis. N. Engl. J. Med. 285 (1971) 1157–1160.

    Google Scholar 

  7. Iwarson, S., Lundin, P., Holmgren, J., Hermodsson, S. Multiple attacks of hepatitis in drug addicts. Immunochemical and histological characteristics. J. Infect. Dis. 127 (1973) 544 to 549.

    Google Scholar 

  8. Redeker, A. G. Chronic Heaptitis. In: The Medical Clinics of North America July 1975, (Ed.:H. J. Zimmermann). Saunders, Philadelphia/London 1975.

    Google Scholar 

  9. Nielsen, J. O., Dietrichson, O., Juhl, E. Incidence and meaning of the “e” determinant among hepatitis B antigen positive patients with acute and chronic liver diseases. Lancet II (1974) 913–915.

    Google Scholar 

  10. Becker, M. D., Scheuer, P. J., Baptista, A., Sherlock, S. Prognosis of chronic persistent hepatitis. Lancet I (1970) 53–57.

    Google Scholar 

  11. Dudley, F. J., Scheuer, P. J., Sherlock, S. Natural history of hepatitis-associated antigen-positive chronic liver disease. Lancet II (1972) 1388–1393.

    Google Scholar 

  12. Stutz, R., Blum, A. L., Haemmerli, U. P., Schmid, P., Schmid, M. A fortuitously controlled study of steroid therapy in acute viral hepatitis. II. Follow-up examination of 202 patients. Am. J. Med. 47 (1969) 93–100.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Norkrans, G., Hermodsson, S., Lundin, P. et al. The long-term outcome of hepatitis B. Infection 4, 70–72 (1976). https://doi.org/10.1007/BF01638719

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01638719

Keywords

Navigation